Watch Ticker

Leap Therapeutics, Inc. Common Stock

Go to Leap Therapeutics, Inc. Common Stock Website

$0.33

0.00 (-0.91%)

Live

Previous Close

$0.329

Day Range

$0.31 - $0.327

Previous Day Range

$0.302 - $0.3399

Market Cap

$14.9 million USD

Day Vol.

457168

Previous Day Vol.

7.3 million

Currency

USD

Primary Exchange

Nasdaq

Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, a...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Metastatic Colorectal Cancer Clinical Trial Pipeline Accelerates as 150+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

The metastatic colorectal cancer pipeline is rapidly expanding, with over 150 pharmaceutical companies developing 180+ pipeline drugs. Novel therapies, including small molecules, antibodies, and tumor microenvironment modulators, are gaining traction and could reshape the treatment landscape.

Related tickers: LPTX, REPL, EXEL.

Read Full Article

Zacks Equity Research - Here's Why Leap Therapeutics (LPTX) is Poised for a Turnaround After Losing -28.92% in 4 Weeks

Leap Therapeutics (LPTX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Related tickers: LPTX.

Read Full Article

Trending Tickers

Please sign in to view